Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Spyre Therapeutics Inc.’s current trading price is -0.49% away from its 52-week high, while its distance from the 52-week low is 1437.22%. The stock’s price range during this period has varied between $2.66 and $41.09. The company, active in the Healthcare sector, saw a trading volume of around 0.51 million for the day, considerably higher average daily volume of 0.39 million observed over the last three months.
In terms of market performance, Spyre Therapeutics Inc. had a somewhat regular. The highest value for the stock in the past year was $41.09 on 03/11/24, while the lowest value was $2.66 on 06/21/23.
How Financial Performance Impacts Market Capitalization
Spyre Therapeutics Inc. (SYRE) has experienced a quarterly rise of 105.89% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.48B and boasts a workforce of 30 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 19.79, with a change in price of +27.13. Similarly, Spyre Therapeutics Inc. recorded 271,643 in trading volume during the last 100 days, posting a change of +197.17%.
How SYRE’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for SYRE stands at 0.46. Similarly, the long-term debt-to-equity ratio is also 0.46.
SYRE Stock Stochastic Average
As of today, the raw stochastic average of Spyre Therapeutics Inc. over the last 50 days is at 96.54%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 96.30%. Further, the company’s Stochastic %K and %D values for the last 20 days were 90.20% and 90.91%, respectively.
SYRE Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Until today this year the stock’s price performance recorded an increase of 90.01%. However, over the last six months, the performance has been weaker by 192.07%. The price of SYRE increased 72.60% over the last 30 days. And in the last five days, it has surged by 16.93%.
